← Leaderboards
Sarah E Glazer
University Of Tx Md Anderson Can Ctr
$111,176
Attributed
$111,176
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.6K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$111,176 · 1
By mechanism
F30$111,176 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ahmed Kaseb$3,699,074
- Jianjun Gao$3,992,332
- Shiaw-Yih Lin$9,839,199
- Ronald Anthony Depinho$97,148,322
- Cassian Yee$17,221,393
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityAftercareAgonistAnimal ModelAntibodiesAnti-CancerAnti-Cancer TherapeuticAntineoplastic AgentsAntitumor EffectBacteriaBiodistributionBone Marrow TransplantationCancer CenterCancer ImagingCancer PatientCancer SurvivalCanis FamiliarisCd276 GeneCellsCheckpoint TherapyChemotherapyClinical TrialsCombatAdaptive Immune System
Grant awards (3)
The Role of Tumor-Targeted TLR5 Activation in Reversing Immune Checkpoint Therapy Resistance$44,610
F30 · FY2022 · CA · contact PI
The Role of Tumor-Targeted TLR5 Activation in Reversing Immune Checkpoint Therapy Resistance$33,541
F30 · FY2021 · CA · contact PI
The Role of Tumor-Targeted TLR5 Activation in Reversing Immune Checkpoint Therapy Resistance$33,025
F30 · FY2020 · CA · contact PI